Safety of novel microbes for human consumption: Practical examples of assessment in the European Union

Autores
Brodmann, Theodor; Endo, Akihito; Gueimonde, Miguel; Vinderola, Celso Gabriel; Kneifel, Wolfgang; de Vos, Willem M.; Salminen, Seppo; Gómez-Gallego, Carlos
Año de publicación
2017
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Novel microbes are either newly isolated genera and species from natural sources or bacterial strains derived from existing bacteria. Novel microbes are gaining increasing attention for the general aims to preserve and modify foods and to modulate gut microbiota. The use of novel microbes to improve health outcomes is of particular interest because growing evidence points to the importance of gut microbiota in human health. As well, some recently isolated microorganisms have promise for use as probiotics, although in-depth assessment of their safety is necessary. Recent examples of microorganisms calling for more detailed evaluation include Bacteroides xylanisolvens, Akkermansia muciniphila, fructophilic lactic acid bacteria (FLAB), and Faecalibacterium prausnitzii. This paper discusses each candidate's safety evaluation for novel food or novel food ingredient approval according to European Union (EU) regulations. The factors evaluated include their beneficial properties, antibiotic resistance profiling, history of safe use (if available), publication of the genomic sequence, toxicological studies in agreement with novel food regulations, and the qualified presumptions of safety. Sufficient evidences have made possible to support and authorize the use of heat-inactivated B. xylanisolvens in the European Union. In the case of A. muciniphila, the discussion focuses on earlier safety studies and the strain's suitability. FLAB are also subjected to standard safety assessments, which, along with their proximity to lactic acid bacteria generally considered to be safe, may lead to novel food authorization in the future. Further research with F. prausnitzii will increase knowledge about its safety and probiotic properties and may lead to its future use as novel food. Upcoming changes in EUU Regulation 2015/2283 on novel food will facilitate the authorization of future novel products and might increase the presence of novel microbes in the food market.
Fil: Brodmann, Theodor. University Of Natural Resources And Life Science Vienna; Austria
Fil: Endo, Akihito. Tokyo University Of Agriculture; Japón
Fil: Gueimonde, Miguel. Consejo Superior de Investigaciones Científicas. Instituto Superior de Productos Lacteos de Asturias; España
Fil: Vinderola, Celso Gabriel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe. Instituto de Lactología Industrial. Universidad Nacional del Litoral. Facultad de Ingeniería Química. Instituto de Lactología Industrial; Argentina
Fil: Kneifel, Wolfgang. Wageningen University And Research; Países Bajos
Fil: de Vos, Willem M.. Wageningen University And Research Centre; . University Of Helsinki Faculty Of Medicine;
Fil: Salminen, Seppo. University of Turku; Finlandia
Fil: Gómez-Gallego, Carlos. University of Turku; Finlandia
Materia
AKKERMANSIA MUCINIPHILA
BACTEROIDES XYLANISOLVENS
FRUCTOPHILIC LACTIC ACID BACTERIA, FAECALIBACTERIUM PRAUSNITZII
NOVEL MICROBES
SAFETY
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/60055

id CONICETDig_08969bf74c25e3923f687955d6ecdae0
oai_identifier_str oai:ri.conicet.gov.ar:11336/60055
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Safety of novel microbes for human consumption: Practical examples of assessment in the European UnionBrodmann, TheodorEndo, AkihitoGueimonde, MiguelVinderola, Celso GabrielKneifel, Wolfgangde Vos, Willem M.Salminen, SeppoGómez-Gallego, CarlosAKKERMANSIA MUCINIPHILABACTEROIDES XYLANISOLVENSFRUCTOPHILIC LACTIC ACID BACTERIA, FAECALIBACTERIUM PRAUSNITZIINOVEL MICROBESSAFETYhttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1Novel microbes are either newly isolated genera and species from natural sources or bacterial strains derived from existing bacteria. Novel microbes are gaining increasing attention for the general aims to preserve and modify foods and to modulate gut microbiota. The use of novel microbes to improve health outcomes is of particular interest because growing evidence points to the importance of gut microbiota in human health. As well, some recently isolated microorganisms have promise for use as probiotics, although in-depth assessment of their safety is necessary. Recent examples of microorganisms calling for more detailed evaluation include Bacteroides xylanisolvens, Akkermansia muciniphila, fructophilic lactic acid bacteria (FLAB), and Faecalibacterium prausnitzii. This paper discusses each candidate's safety evaluation for novel food or novel food ingredient approval according to European Union (EU) regulations. The factors evaluated include their beneficial properties, antibiotic resistance profiling, history of safe use (if available), publication of the genomic sequence, toxicological studies in agreement with novel food regulations, and the qualified presumptions of safety. Sufficient evidences have made possible to support and authorize the use of heat-inactivated B. xylanisolvens in the European Union. In the case of A. muciniphila, the discussion focuses on earlier safety studies and the strain's suitability. FLAB are also subjected to standard safety assessments, which, along with their proximity to lactic acid bacteria generally considered to be safe, may lead to novel food authorization in the future. Further research with F. prausnitzii will increase knowledge about its safety and probiotic properties and may lead to its future use as novel food. Upcoming changes in EUU Regulation 2015/2283 on novel food will facilitate the authorization of future novel products and might increase the presence of novel microbes in the food market.Fil: Brodmann, Theodor. University Of Natural Resources And Life Science Vienna; AustriaFil: Endo, Akihito. Tokyo University Of Agriculture; JapónFil: Gueimonde, Miguel. Consejo Superior de Investigaciones Científicas. Instituto Superior de Productos Lacteos de Asturias; EspañaFil: Vinderola, Celso Gabriel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe. Instituto de Lactología Industrial. Universidad Nacional del Litoral. Facultad de Ingeniería Química. Instituto de Lactología Industrial; ArgentinaFil: Kneifel, Wolfgang. Wageningen University And Research; Países BajosFil: de Vos, Willem M.. Wageningen University And Research Centre; . University Of Helsinki Faculty Of Medicine;Fil: Salminen, Seppo. University of Turku; FinlandiaFil: Gómez-Gallego, Carlos. University of Turku; FinlandiaFrontiers Media S.A.2017-09info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/60055Brodmann, Theodor; Endo, Akihito; Gueimonde, Miguel; Vinderola, Celso Gabriel; Kneifel, Wolfgang; et al.; Safety of novel microbes for human consumption: Practical examples of assessment in the European Union; Frontiers Media S.A.; Frontiers in Microbiology; 8; 9-2017; 1-151664-302XCONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/http://journal.frontiersin.org/article/10.3389/fmicb.2017.01725/fullinfo:eu-repo/semantics/altIdentifier/doi/10.3389/fmicb.2017.01725info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:07:36Zoai:ri.conicet.gov.ar:11336/60055instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:07:36.388CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Safety of novel microbes for human consumption: Practical examples of assessment in the European Union
title Safety of novel microbes for human consumption: Practical examples of assessment in the European Union
spellingShingle Safety of novel microbes for human consumption: Practical examples of assessment in the European Union
Brodmann, Theodor
AKKERMANSIA MUCINIPHILA
BACTEROIDES XYLANISOLVENS
FRUCTOPHILIC LACTIC ACID BACTERIA, FAECALIBACTERIUM PRAUSNITZII
NOVEL MICROBES
SAFETY
title_short Safety of novel microbes for human consumption: Practical examples of assessment in the European Union
title_full Safety of novel microbes for human consumption: Practical examples of assessment in the European Union
title_fullStr Safety of novel microbes for human consumption: Practical examples of assessment in the European Union
title_full_unstemmed Safety of novel microbes for human consumption: Practical examples of assessment in the European Union
title_sort Safety of novel microbes for human consumption: Practical examples of assessment in the European Union
dc.creator.none.fl_str_mv Brodmann, Theodor
Endo, Akihito
Gueimonde, Miguel
Vinderola, Celso Gabriel
Kneifel, Wolfgang
de Vos, Willem M.
Salminen, Seppo
Gómez-Gallego, Carlos
author Brodmann, Theodor
author_facet Brodmann, Theodor
Endo, Akihito
Gueimonde, Miguel
Vinderola, Celso Gabriel
Kneifel, Wolfgang
de Vos, Willem M.
Salminen, Seppo
Gómez-Gallego, Carlos
author_role author
author2 Endo, Akihito
Gueimonde, Miguel
Vinderola, Celso Gabriel
Kneifel, Wolfgang
de Vos, Willem M.
Salminen, Seppo
Gómez-Gallego, Carlos
author2_role author
author
author
author
author
author
author
dc.subject.none.fl_str_mv AKKERMANSIA MUCINIPHILA
BACTEROIDES XYLANISOLVENS
FRUCTOPHILIC LACTIC ACID BACTERIA, FAECALIBACTERIUM PRAUSNITZII
NOVEL MICROBES
SAFETY
topic AKKERMANSIA MUCINIPHILA
BACTEROIDES XYLANISOLVENS
FRUCTOPHILIC LACTIC ACID BACTERIA, FAECALIBACTERIUM PRAUSNITZII
NOVEL MICROBES
SAFETY
purl_subject.fl_str_mv https://purl.org/becyt/ford/1.6
https://purl.org/becyt/ford/1
dc.description.none.fl_txt_mv Novel microbes are either newly isolated genera and species from natural sources or bacterial strains derived from existing bacteria. Novel microbes are gaining increasing attention for the general aims to preserve and modify foods and to modulate gut microbiota. The use of novel microbes to improve health outcomes is of particular interest because growing evidence points to the importance of gut microbiota in human health. As well, some recently isolated microorganisms have promise for use as probiotics, although in-depth assessment of their safety is necessary. Recent examples of microorganisms calling for more detailed evaluation include Bacteroides xylanisolvens, Akkermansia muciniphila, fructophilic lactic acid bacteria (FLAB), and Faecalibacterium prausnitzii. This paper discusses each candidate's safety evaluation for novel food or novel food ingredient approval according to European Union (EU) regulations. The factors evaluated include their beneficial properties, antibiotic resistance profiling, history of safe use (if available), publication of the genomic sequence, toxicological studies in agreement with novel food regulations, and the qualified presumptions of safety. Sufficient evidences have made possible to support and authorize the use of heat-inactivated B. xylanisolvens in the European Union. In the case of A. muciniphila, the discussion focuses on earlier safety studies and the strain's suitability. FLAB are also subjected to standard safety assessments, which, along with their proximity to lactic acid bacteria generally considered to be safe, may lead to novel food authorization in the future. Further research with F. prausnitzii will increase knowledge about its safety and probiotic properties and may lead to its future use as novel food. Upcoming changes in EUU Regulation 2015/2283 on novel food will facilitate the authorization of future novel products and might increase the presence of novel microbes in the food market.
Fil: Brodmann, Theodor. University Of Natural Resources And Life Science Vienna; Austria
Fil: Endo, Akihito. Tokyo University Of Agriculture; Japón
Fil: Gueimonde, Miguel. Consejo Superior de Investigaciones Científicas. Instituto Superior de Productos Lacteos de Asturias; España
Fil: Vinderola, Celso Gabriel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe. Instituto de Lactología Industrial. Universidad Nacional del Litoral. Facultad de Ingeniería Química. Instituto de Lactología Industrial; Argentina
Fil: Kneifel, Wolfgang. Wageningen University And Research; Países Bajos
Fil: de Vos, Willem M.. Wageningen University And Research Centre; . University Of Helsinki Faculty Of Medicine;
Fil: Salminen, Seppo. University of Turku; Finlandia
Fil: Gómez-Gallego, Carlos. University of Turku; Finlandia
description Novel microbes are either newly isolated genera and species from natural sources or bacterial strains derived from existing bacteria. Novel microbes are gaining increasing attention for the general aims to preserve and modify foods and to modulate gut microbiota. The use of novel microbes to improve health outcomes is of particular interest because growing evidence points to the importance of gut microbiota in human health. As well, some recently isolated microorganisms have promise for use as probiotics, although in-depth assessment of their safety is necessary. Recent examples of microorganisms calling for more detailed evaluation include Bacteroides xylanisolvens, Akkermansia muciniphila, fructophilic lactic acid bacteria (FLAB), and Faecalibacterium prausnitzii. This paper discusses each candidate's safety evaluation for novel food or novel food ingredient approval according to European Union (EU) regulations. The factors evaluated include their beneficial properties, antibiotic resistance profiling, history of safe use (if available), publication of the genomic sequence, toxicological studies in agreement with novel food regulations, and the qualified presumptions of safety. Sufficient evidences have made possible to support and authorize the use of heat-inactivated B. xylanisolvens in the European Union. In the case of A. muciniphila, the discussion focuses on earlier safety studies and the strain's suitability. FLAB are also subjected to standard safety assessments, which, along with their proximity to lactic acid bacteria generally considered to be safe, may lead to novel food authorization in the future. Further research with F. prausnitzii will increase knowledge about its safety and probiotic properties and may lead to its future use as novel food. Upcoming changes in EUU Regulation 2015/2283 on novel food will facilitate the authorization of future novel products and might increase the presence of novel microbes in the food market.
publishDate 2017
dc.date.none.fl_str_mv 2017-09
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/60055
Brodmann, Theodor; Endo, Akihito; Gueimonde, Miguel; Vinderola, Celso Gabriel; Kneifel, Wolfgang; et al.; Safety of novel microbes for human consumption: Practical examples of assessment in the European Union; Frontiers Media S.A.; Frontiers in Microbiology; 8; 9-2017; 1-15
1664-302X
CONICET Digital
CONICET
url http://hdl.handle.net/11336/60055
identifier_str_mv Brodmann, Theodor; Endo, Akihito; Gueimonde, Miguel; Vinderola, Celso Gabriel; Kneifel, Wolfgang; et al.; Safety of novel microbes for human consumption: Practical examples of assessment in the European Union; Frontiers Media S.A.; Frontiers in Microbiology; 8; 9-2017; 1-15
1664-302X
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/http://journal.frontiersin.org/article/10.3389/fmicb.2017.01725/full
info:eu-repo/semantics/altIdentifier/doi/10.3389/fmicb.2017.01725
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Frontiers Media S.A.
publisher.none.fl_str_mv Frontiers Media S.A.
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1844613937252794368
score 13.070432